PROTEUS Trial the Day After: Practice Changing or Premature Escalation?

European Urology Oncology·July 1

Summary

What was studied

Commentary evaluating the PROTEUS trial findings and whether they represent a practice-changing advance or premature escalation in treatment strategy, published in European Urology Oncology.

Study limitations

The source text provides only the title, DOI, journal, and publication date — no abstract, methods, results, or discussion content is available for extraction.

Related Questions

Explore related topics

What are the key findings of the PROTEUS trial in prostate cancer?What were the key outcomes of the PROTEUS trial in prostate cancer?Is neoadjuvant or adjuvant androgen receptor pathway inhibition before radical prostatectomy practice changing?Does adding darolutamide to androgen deprivation therapy before radical prostatectomy improve survival outcomes?What does the PROTEUS trial mean for localized high-risk prostate cancer management?Neoadjuvant androgen receptor pathway inhibitors in localized prostate cancer: current evidence

Keep scrolling